President Trump to hold White House COVID-19 summit as pressure mounts for FDA vaccine approval

President Donald Trump is set to kick off a summit at the White House Tuesday to highlight the rapid development of a COVID-19 vaccine he is eager to take credit for despite criticism for his handling of the coronavirus pandemic.

The summit, designed to provide an update on the status of the administration's ambitious plan to vaccinate all Americans against the coronavirus, comes two days before the FDA advisory committee will meet to review Pfizer and BioNTech's application for emergency authorization of their COVID-19 vaccine and distribution is expected to begin within 24 hours of authorization. The FDA will also meet on Dec. 17 to review Moderna's emergency request for its vaccine.